MyMD Pharmaceuticals regains Nasdaq minimum bid price compliance after reverse stock split

Q/C TECHNOLOGIES, INC.

Received notice from Nasdaq on March 4, 2024 that it has regained compliance with Listing Rule 5550(a)(2).
Deficiency flagged Oct 11, 2023 after shares failed to maintain $1.00 bid for 30 consecutive days.
Conducted a 1-for-30 reverse stock split on Feb 14, 2024; split-adjusted trading began Feb 15.
Minimum bid price of $1.00 maintained for 10 consecutive business days, requirement met on March 1, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.